研究者業績

坂倉 建一

Sakakura Kenichi  (Kenichi Sakakura)

基本情報

所属
自治医科大学 附属さいたま医療センター心血管治療部 教授 (心血管治療部長)
(兼任)附属さいたま医療センター循環器内科 教授
学位
医学博士(自治医科大学)

研究者番号
20773310
J-GLOBAL ID
201501004058346154
Researcher ID
AAK-4564-2020
researchmap会員ID
B000247981

学歴

 1

論文

 321
  • Takunori Tsukui, Kenichi Sakakura, Yousuke Taniguchi, Kei Yamamoto, Masaru Seguchi, Hiroshi Wada, Shin-Ichi Momomura, Hideo Fujita
    Internal medicine (Tokyo, Japan) 59(13) 1597-1603 2020年  査読有り
    Objective In primary percutaneous coronary intervention (PCI), the door-to-balloon time (DTBT) is known to be associated with in-hospital death in patients with ST-segment elevation myocardial infarction (STEMI). However, little is known regarding the association between the DTBT and the mid-term clinical outcomes in patients with STEMI. The purpose of this study was to investigate the association between the DTBT and mid-term all-cause death. Methods The study population included 309 STEMI patients, who were divided into the short DTBT (DTBT<60 minutes, n=103), intermediate DTBT (DTBT 60-120 minutes, n=174) and long DTBT (DTBT >120 minutes, n=32) groups. The median follow-up period was 287 days (interquartile range: 182-624 days). Results The incidence of all-cause death in the long DTBT group was significantly higher in comparison to the other groups (p<0.001). In the multivariate Cox regression analysis, although a short DTBT [vs. intermediate DTBT: hazard ratio (HR) 1.00, 95% confidence interval (CI) 0.39-2.55, p=0.99] was not associated with all-cause death, a long DTBT (vs. intermediate DTBT: HR 2.80, 95% CI 1.26-6.17, p=0.011) was significantly associated with all-cause death, after controlling for confounding factors such as Killip class 4, an impaired renal function, and the number of diseased vessels. Conclusion The DTBT was significantly associated with the incidence of mid-term all-cause death. Our results support the strong adherence to the DTBT in patients with STEMI.
  • Kei Yamamoto, Kenichi Sakakura, Takunori Tsukui, Masaru Seguchi, Yousuke Taniguchi, Hiroshi Wada, Shin-Ichi Momomura, Hideo Fujita
    PloS one 15(4) e0232158 2020年  査読有り
    BACKGROUND: Recently, the importance of chronic total occlusion (CTO)-percutaneous coronary intervention (PCI) has been emphasized with greater success rates. In the antegrade wire based approach, it is generally considered that the guidewire would not advance from the subintimal space to the intimal space without dissection re-entry device. However, it is sometimes observed by intravascular ultrasound (IVUS) that the guidewire within the subintimal space advanced into the distal true lumen. The purpose of this study was to investigate specific conditions or characteristics which were associated with "antegrade true-sub-true" phenomenon in CTO-PCI. METHODS: We retrospectively reviewed consecutive 320 CTO lesions that underwent CTO-PCI in our institution. Among them, 16 lesions in which the IVUS confirmed the "antegrade true-sub-true" phenomenon were categorized as the true-sub-true group, whereas 27 lesions that resulted in unsuccessful CTO-PCI were categorized as the unsuccessful group. We compared the clinical, lesion, and procedural characteristics between the true-sub-true group and the unsuccessful group. RESULTS: The prevalence of bifurcation with abrupt type in CTO exit-sites was significantly higher in the true-sub-true group in comparison to the unsuccessful group (75.0% vs. 25.9%, p = 0.002). The multivariate logistic regression analysis revealed that bifurcation with abrupt type in CTO exit-site (OR 8.017; 95%CI: 1.484-43.304; p = 0.016) was independent predictor of the antegrade true-sub-true phenomenon. CONCLUSIONS: In CTO-PCI, the antegrade true-sub-true phenomenon is rare, but can be a last chance for successful PCI. Bifurcation with abrupt type in CTO exit-site was significantly associated with the antegrade true-sub-true phenomenon.
  • Taku Kasahara, Kenichi Sakakura, Shin-Ichi Momomura, Hideo Fujita
    Journal of cardiology cases 21(1) 32-34 2020年1月  査読有り
    A reverse guidewire technique along with double lumen catheter has become a standard technique for extremely angulated bifurcation lesions. A-72-year-old male underwent coronary angiography, which revealed a severe stenosis of the left anterior descending artery with an extremely angulated diagonal branch. We introduced the Crusade (Kaneka, Osaka, Japan) accompanied with the reversed guidewire to the lesion, but the Crusade with the reversed guidewire could not cross the lesion. We kept the Crusade at the just proximal to the stenosis, and advanced the only reversed guidewire to the lesion. The reversed guidewire successfully crossed the lesion, and then we pulled back the reversed guidewire to lead the reversed guidewire's tip into the diagonal branch retrogradely. In this modified reverse guidewire technique, the Crusade does not need to cross the lesion, but needs to bring the reversed guidewire at the just proximal of the lesion. Because the profile of the reversed guidewire alone is smaller than that of the Crusade accompanied with the reversed guidewire, the reversed guidewire alone has greater chance to cross the severe stenosis. Our modification may increase the success rate of the reverse guidewire technique, and expand the indication of this technique. <Learning objective: In a reverse guidewire technique, if there is a severe stenosis at just proximal of the bifurcation lesion, it may be difficult to cross the double lumen catheter with a reversed guidewire beyond the bifurcation lesion, because the profile of the double lumen catheter accompanied with a reversed guidewire is much larger than the double lumen catheter or the reversed guidewire alone. We modified reverse guidewire technique, which may increase the success rate of the reverse guidewire technique.>.
  • Wataru Sasaki, Hiroshi Wada, Kenichi Sakakura, Jun Matsuda, Tatsuro Ibe, Takekuni Hayashi, Hirohito Ueba, Shin-Ichi Momomura, Hideo Fujita
    Clinical case reports 8(1) 190-193 2020年1月  査読有り
    Vascular toxicity is one of serious complications following cisplatin-based chemotherapy. This case suggests that cisplatin has a potential risk of delayed occurrence of vasospastic angina. It is important to perform careful history taking including discontinued drugs for differential diagnosis of chest pain.
  • Hiroko Hasegawa, Kenichi Sakakura, Kohei Hamamoto, Kei Yamamoto, Yousuke Taniguchi, Takunori Tsukui, Masaru Seguchi, Hiroshi Wada, Shin-Ichi Momomura, Hideo Fujita
    Cardiovascular revascularization medicine : including molecular interventions 21(1) 6-11 2020年1月  査読有り
    BACKGROUND: Skin radiation injuries, especially radiation ulcers, are serious side effects caused by ionizing radiation during percutaneous coronary interventions (PCI). Because skin radiation injuries are closely associated with the peak skin dose, it is important to minimize the peak skin dose. The aim of the present study was to investigate the determinants of greater peak skin dose in current PCI. METHODS: We included 707 consecutive coronary artery lesions, and divided them into an excess radiation group (n = 26; defined as peak skin dose ≥2 Gy) and a standard radiation group (n = 681; defined as peak skin dose <2 Gy). Clinical, lesion, and procedural characteristics were compared between the 2 groups. Univariate and multivariate logistic regression analyses were performed to identify determinants of the excess radiation group. RESULTS: A multivariate logistic regression analysis revealed that body surface area (BSA) [0.1 m2 increase: odds ratio (OR) 1.39, 95% confidence interval (CI) 1.13-1.71, P < 0.01], PCI to a right coronary artery (RCA) (OR 3.11, 95% CI 1.35-7.17, P < 0.01), and PCI to a chronic total occlusion (CTO) (OR 6.69, 95% CI 2.65-16.87, P < 0.01) were significantly associated with the excess radiation group. CONCLUSIONS: Greater BSA, PCI to RCA lesions, and PCI to CTO lesions were significantly associated with excess radiation dose. The first step in the prevention of radiation injuries in current PCI will be to recognize these risk factors.
  • Jumpei Ohashi, Kenichi Sakakura, Kei Yamamoto, Yousuke Taniguchi, Takunori Tsukui, Masaru Seguchi, Hitomi Nanba-Sato, Kaho Shibata, Wataru Sasaki, Tomoya Ikeda, Hiroshi Wada, Shin-Ichi Momomura, Hideo Fujita
    International heart journal 60(6) 1245-1252 2019年11月30日  査読有り
    Persistent severe left ventricular (LV) systolic dysfunction after acute myocardial infarction (AMI) is associated with increased morbidity and mortality, whereas mid-term recovery of LV systolic function after AMI is associated with better long-term outcomes. The purpose of this study was to investigate the determinants of mid-term improvement of LV ejection fraction (EF) in AMI patients. We included 210 AMI patients who had modified Simpson EF both at the index admission and mid-term follow up. The difference of EF between the index admission and mid-term follow-up was calculated in all study patients. The EF improvement group was defined as mid-term ≥ 10% EF increase compared with the index admission EF. Of 210 AMI patients, 46 (21.9%) were allocated to the EF improvement group and 164 (78.1%) to the non-EF improvement group. Brain natriuretic peptide (BNP) at the timing of admission was significantly greater in the EF improvement group (735.8 ± 1077.6 pg/mL) than in the non-EF improvement group (239.0 ± 419.8 pg/mL) (P < 0.001). Multivariate logistic regression analysis revealed that log10 BNP at the timing of admission (OR 3.36, 95% CI 1.69-6.66, P < 0.001) and left main trunk-left anterior descending artery (LM-LAD) as the infarct-related artery (OR 3.34, 95% CI 1.59-7.02, P = 0.001) were significantly associated with EF improvement. In conclusion, elevated BNP at the timing of admission and LM-LAD as the infarct-related artery were significantly associated with mid-term LVEF recovery. Our results support aggressive acute treatment for those severe AMI, because the possibility of mid-term LVEF recovery is greater compared with other AMI.
  • Yousuke Taniguchi, Kenichi Sakakura, Koichi Yuri, Yohei Nomura, Yusuke Tamanaha, Naoyuki Akashi, Takunori Tsukui, Kei Yamamoto, Hiroshi Wada, Shin-Ichi Momomura, Atsushi Yamaguchi, Hideo Fujita
    International heart journal 60(6) 1350-1357 2019年11月30日  査読有り
    Transcatheter aortic valve implantation (TAVI) has been recognized as a standard therapy for severe aortic valve stenosis. However, since some patients who receive TAVI have poor outcomes, the predictors of clinical outcomes after TAVI are important. The aim of this study was to investigate the association between appetite and long-term clinical outcomes.We screened consecutive cases who received TAVI at our medical center between July 2014 and October 2018. A total of 139 patients who received transfemoral TAVI were included as the final study population. They were divided into a good appetite group (n = 105) and a less appetite group (n = 34) according to their dietary intake rate (> 90%: good appetite group, ≤ 90%: less appetite group). We defined the intake rate as the average for breakfast, lunch, and dinner on the day just before discharge. We defined two-year major adverse cardiovascular and cerebrovascular events (MACCE) as a composite of cardiovascular death, myocardial infarction, any coronary revascularization, history of hospitalization due to heart failure, and disabling acute cerebral infarction. Kaplan-Meier analyses and multivariate Cox regression analysis were performed.The median duration of the follow-up period was 372 (189-720) days. Kaplan-Meier curves showed that the less appetite group got MACCE more frequently (event free rate of the less appetite group: 76.5% versus the good appetite group: 94.3%, Log Rank P = 0.01). In multivariate Cox regression analysis, having less appetite was a significant predictor of two-year MACCE (HR 5.26, 95%CI 1.66-16.71, P < 0.01).In conclusion, among the patients who received transfemoral TAVI, appetite status just before discharge was significantly associated with long-term outcome.
  • 山本 慶, 坂倉 建一, 津久井 卓伯, 瀬口 優, 谷口 陽介, 和田 浩, 百村 伸一, 藤田 英雄
    日本臨床生理学会雑誌 49(4) 89-89 2019年10月  査読有り
  • Yusuke Tamanaha, Kenichi Sakakura, Yousuke Taniguchi, Kei Yamamoto, Takunori Tsukui, Masaru Seguchi, Hiroshi Wada, Shin-Ichi Momomura, Hideo Fujita
    International heart journal 60(5) 1030-1036 2019年9月27日  査読有り
    Postcatheterization pseudoaneurysm is a serious complication following diagnostic or therapeutic catheterization. Because radial access is unsuitable in some situations, there is still a need to use femoral or brachial access for arterial catheterization. The aim of this study was to compare the incidence and clinical characteristics of pseudoaneurysm between brachial and femoral access. We identified patients who underwent arterial catheterization from our cardiac catheter records. A total of 5,990 cardiac catheter records and discharge summaries were reviewed, and 23 pseudoaneurysm cases were identified. Those pseudoaneurysm cases were divided into a brachial pseudoaneurysm group (n = 9) and a femoral pseudoaneurysm group (n = 14). The incidence of pseudoaneurysm was significantly higher in brachial access than in femoral access (odds ratio: 4.16, 95% confidence interval: 1.80-9.65; P < 0.001). Successful manual compression was frequently achieved in both the brachial (77.8%) and the femoral (92.9%) pseudoaneurysm groups (P = 0.295). Surgical intervention was more frequently performed in the brachial pseudoaneurysm group (22.2%) than in the femoral pseudoaneurysm group (0%) without reaching statistical significance (P = 0.07). Moreover, neurological disorders were observed only in the brachial pseudoaneurysm group (22.2%). In conclusion, the incidence of pseudoaneurysm was significantly higher in brachial access than in femoral access, indicating the potential risk of brachial access. Successful manual compression was frequently achieved in both groups, but neurological disorders were observed only in brachial access, suggesting the greater risk of brachial pseudoaneurysms.
  • 石橋 峻, 津久井 卓伯, 坂倉 建一, 谷口 陽介, 山本 慶, 瀬口 優, 百村 伸一, 藤田 英雄
    日本心血管インターベンション治療学会抄録集 28回 [MP3-005] 2019年9月  査読有り
  • 山本 慶, 坂倉 建一, 津久井 卓伯, 瀬口 優, 和田 浩, 百村 伸一, 藤田 英雄
    日本心血管インターベンション治療学会抄録集 28回 [MO79-001] 2019年9月  査読有り
  • 津久井 卓伯, 谷口 陽介, 長谷川 宏子, 成田 昌隆, 玉那覇 雄介, 笠原 卓, 山本 慶, 宇賀田 裕介, 瀬口 優, 坂倉 建一, 和田 浩, 百村 伸一, 藤田 英雄, 今村 有佑, 野村 陽平, 由利 康一, 山口 敦司
    日本心血管インターベンション治療学会抄録集 28回 [MO103-001] 2019年9月  査読有り
  • 長谷川 宏子, 谷口 陽介, 玉那覇 雄介, 笠原 卓, 津久井 卓伯, 山本 慶, 瀬口 優, 坂倉 建一, 和田 浩, 百村 伸一, 藤田 英雄, 今村 有佑, 野村 陽平, 由利 康一, 山口 敦司, 岩崎 夢大, 大塚 祐史
    日本心血管インターベンション治療学会抄録集 28回 [MO103-002] 2019年9月  査読有り
  • Akira Otani, Kenichi Sakakura, Kei Yamamoto, Yousuke Taniguchi, Miyuki Ito, Tatsuro Ibe, Hiroshi Wada, Shin-ichi Momomura, Hideo Fujita
    Heart and Vessels 34(8) 1288-1296 2019年8月1日  
  • Yamamoto K, Sakakura K, Akashi N, Watanabe Y, Noguchi M, Taniguchi Y, Wada H, Momomura SI, Fujita H
    Heart and vessels 34(7) 1096-1103 2019年7月  査読有り
  • Ito M, Wada H, Sakakura K, Ibe T, Ugata Y, Fujita H, Momomura SI
    International heart journal 60(4) 862-869 2019年7月  査読有り
  • Yamamoto K, Sakakura K, Akashi N, Watanabe Y, Seguchi M, Taniguchi Y, Wada H, Momomura SI, Fujita H
    Journal of cardiology 2019年7月  査読有り
  • Kenichi Sakakura, Yousuke Taniguchi, Kei Yamamoto, Hiroshi Wada, Shinichi Momomura, Hideo Fujita
    PLoS ONE 14(7) 2019年6月1日  
  • Taniguchi Y, Sakakura K, Mukai Y, Yamamoto K, Momomura SI, Fujita H
    Journal of cardiology cases 19(6) 200-203 2019年6月  査読有り
  • Masamitsu Noguchi, Kenichi Sakakura, Naoyuki Akashi, Yusuke Adachi, Yusuke Watanabe, Yousuke Taniguchi, Tatsuro Ibe, Kei Yamamoto, Hiroshi Wada, Shin-Ichi Momomura, Hideo Fujita
    International heart journal 60(3) 560-568 2019年5月30日  査読有り
    Right ventricular infarction (RVI) is a complication following inferior ST-elevation myocardial infarction (STEMI). The aim of the present study was to investigate the clinical outcomes of RVI in the contemporary primary percutaneous coronary intervention (PCI) era. The primary endpoint was in-hospital death, and the secondary endpoint was major adverse cardiac events (MACE), defined as the composite of cardiovascular death, re-hospitalization for heart failure, and non-fatal acute myocardial infarction (AMI). Event-free survival curves for MACE were constructed using the Kaplan-Meier method, and statistical differences between curves were assessed using the log-lank test. A total of 1354 patients with AMI were screened from January 2010 to December 2016. The final study population involved 315 patients with STEMI whose infarct related artery (IRA) was the right coronary artery (RCA). We categorized these 315 patients into the RVI group (n = 85) and the non-RVI group (n = 230). Median follow-up duration was 358 (IQR: 208-987) days. In-hospital deaths were more frequently observed in the RVI group (9.4%) than in the non-RVI group (3.0%) (P = 0.018). However, the incidence of MACE was not different between the groups (P = 0.537). In conclusion, in-hospital clinical outcomes were poorer in the RVI group than in the non-RVI group. However, mid-term MACE was not different between the two groups, suggesting the importance of aggressive acute treatment for STEMI patients with RVI.
  • Ibe T, Wada H, Sakakura K, Yoshimura S, Ito M, Ugata Y, Yamamoto K, Seguchi M, Taniguchi Y, Momomura SI, Fujita H
    Heart and vessels 2019年5月  査読有り
  • Watanabe Y, Sakakura K, Kotoku H, Mashimo S, Nakata M, Nagata H, Chiba Y, Kojima M
    Journal of rural medicine : JRM 14(1) 116-119 2019年5月  査読有り
  • Sakakura K, Taniguchi Y, Yamamoto K, Wada H, Momomura SI, Fujita H
    Cardiovascular revascularization medicine : including molecular interventions 2019年5月  査読有り
  • Kenichi Sakakura, Shin-ichi Momomura, Hideo Fujita
    Cardiovascular Intervention and Therapeutics 34(2) 182-183 2019年4月15日  
  • Yamamoto K, Sakakura K, Akashi N, Watanabe Y, Noguchi M, Seguchi M, Taniguchi Y, Ugata Y, Wada H, Momomura SI, Fujita H
    Circulation journal : official journal of the Japanese Circulation Society 83(5) 1039-1046 2019年4月  査読有り
  • Yusuke Adachi, Takekuni Hayashi, Takeshi Mitsuhashi, Kenichi Sakakura, Yoko Yamada, Yuko Wada, Minoru Horie, Shin-Ichi Momomura, Hideo Fujita
    BMC cardiovascular disorders 19(1) 41-41 2019年2月19日  査読有り
    BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited myocardial disease characterized by fibrofatty replacement and ventricular arrhythmias. ARVC is believed to be a disease of the young, with most cases being diagnosed before the age of 40 years. We report here a case of newly diagnosed ARVC in an octogenarian associated with a pathogenic variant in the plakophilin 2 gene (PKP2). CASE PRESENTATION: An 80-year-old Japanese man was referred for sustained ventricular tachycardia. His baseline electrocardiogram showed negative T waves in V1-V4. Right ventriculography showed right ventricular aneurysm. Because this case met three major criteria, ARVC was diagnosed. He was successfully treated with radiofrequency ablation and oral amiodarone. Genetic analysis identified an insertion mutation in exon 8 of PKP2 (1725_1728dupGATG), which caused a frameshift and premature termination of translation (R577DfsX5). CONCLUSIONS: To the best of our knowledge, this is the first report of newly diagnosed ARVC in an octogenarian associated with a loss-of-function PKP2 pathogenic variant. Although the late clinical presentation of ARVC is rare, it should be included in the differential diagnosis when treating older patients with ventricular tachyarrhythmias.
  • Sakaoka A, Rousselle SD, Hagiwara H, Tellez A, Hubbard B, Sakakura K
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 93(3) 494-502 2019年2月  査読有り
  • Ishibashi S, Sakakura K, Yamamoto K, Okochi T, Momomura SI, Fujita H
    Clinical case reports 7(2) 391-393 2019年2月  査読有り
  • Yousuke Taniguchi, Kenichi Sakakura, Koichi Yuri, Yusuke Imamura, Takunori Tsukui, Kei Yamamoto, Hiroshi Wada, Shin-Ichi Momomura, Atsushi Yamaguchi, Hideo Fujita
    Postepy w kardiologii interwencyjnej = Advances in interventional cardiology 15(4) 431-438 2019年  査読有り
    Introduction: Transcatheter aortic valve implantation (TAVI) has grown to be an alternative treatment for severe symptomatic aortic valve stenosis (AS) in elderly patients. Although TAVI is a less invasive surgery than surgical aortic valve replacement, some patients may require prolonged hospitalization. Aim: To find the determinants of prolonged hospitalization in patients who underwent trans-femoral TAVI. Material and methods: A total of 94 AS patients who underwent trans-femoral TAVI were included as the final study population, and divided into the conventional hospitalization group (≤ 21 days) (n = 74) and prolonged hospitalization group (> 21 days) (n = 20). We compared clinical characteristics between the two groups, and multivariate logistic regression analysis was performed to find the determinants of prolonged hospitalization. Results: In multivariate logistic regression analysis, moderate or severe mitral regurgitation (OR = 4.49, 95% CI: 1.16-17.47, p = 0.03), taking statins or angiotensin converting enzyme (ACE) inhibitors/angiotensin II receptor blockers (ARB) on admission (statins: OR = 0.13, 95% CI: 0.02-0.71, p = 0.02, ACE inhibitors/ARB: OR = 0.25, 95% CI: 0.06-0.96, p = 0.04), estimated glomerular filtration rate (eGFR) (per 15 ml/min/1.73 m2 incremental) (OR = 0.49, 95% CI: 0.26-0.90, p = 0.02) and current chopsticks user (OR = 0.05, 95% CI: 0.01-0.41, p < 0.01) were significantly associated with prolonged hospitalization. Conclusions: Moderate or severe mitral regurgitation was significantly associated with prolonged hospitalization, while current chopsticks user, eGFR (per 15 ml/min/1.73 m2 incremental), taking ACE inhibitors/ARB or statins before the procedure were inversely associated with prolonged hospitalization in patients who underwent trans-femoral TAVI.
  • Narita M, Sakakura K, Ohashi J, Ibe T, Yamamoto K, Wada H, Momomura SI, Fujita H
    International heart journal 60(1) 215-219 2019年1月  査読有り
  • Yamamoto K, Sakakura K, Akashi N, Watanabe Y, Noguchi M, Taniguchi Y, Wada H, Momomura SI, Fujita H
    International heart journal 60(1) 37-44 2019年1月  査読有り
  • Watanabe Y, Sakakura K, Taniguchi Y, Yamamoto K, Wada H, Momomura SI, Fujita H
    International heart journal 59(6) 1237-1245 2018年11月  査読有り
  • Yousuke Taniguchi, Kenichi Sakakura, Yusuke Adachi, Naoyuki Akashi, Yusuke Watanabe, Masamitsu Noguchi, Kei Yamamoto, Yusuke Ugata, Hiroshi Wada, Shin-Ichi Momomura, Hideo Fujita
    Cardiovascular intervention and therapeutics 33(4) 338-344 2018年10月  査読有り
    In-hospital outcomes of acute myocardial infarction (AMI) with cardiogenic shock (CS) were still not satisfactory even in the primary percutaneous coronary intervention (PCI) era. The aim of this study was to compare in-hospital outcomes of AMI with CS caused by right coronary artery (RCA) occlusion vs. left coronary artery (LCA) occlusion. Consecutive 894 AMI patients from January 2010 to March 2015 were screened for inclusion. A total of 114 AMI patients with CS were included as the final study population, and were divided into the RCA group (n = 56) and LCA group (n = 58). The patient characteristics were compared between the two groups. Multivariate logistic regression analysis was performed to show whether the RCA group was associated with better outcomes even after controlling confounding factors. In-hospital mortality was significantly lower in the RCA group (8.9%) than in the LCA group (46.6%) (P < 0.001). The RCA group (vs. the LCA group) was inversely associated with in-hospital death (OR 0.08, 95% CI 0.02-0.21, P < 0.001) after controlling covariates. Aspartate transaminase value (per 50 U/L incremental: OR 1.22, 95% CI 1.03-1.45, P = 0.02), aging (per 10-year-old incremental: OR 2.14, 95% CI 1.26-3.63, P = 0.01) and using VA-ECMO (OR 22.13, 95% CI 5.22-93.90, P < 0.001) were also significantly associated with in-hospital death. In conclusion, among AMI patients with CS, IRA of RCA was significantly associated with the better in-hospital outcome.
  • Yamamoto K, Sakakura K, Akashi N, Watanabe Y, Noguchi M, Taniguchi Y, Ugata Y, Wada H, Momomura SI, Fujita H
    Journal of cardiology 72(3) 227-233 2018年9月  査読有り
  • Ibe T, Wada H, Sakakura K, Ito M, Ugata Y, Yamamoto K, Taniguchi Y, Momomura SI, Fujita H
    International heart journal 59(5) 1047-1051 2018年9月  査読有り
  • Jinnouchi H, Sakakura K, Fujita H
    Journal of thoracic disease 10(Suppl 26) S3176-S3181 2018年9月  査読有り
  • 谷口 陽介, 由利 康一, 今村 有佑, 伊藤 みゆき, 玉那覇 雄介, 津久井 卓伯, 和田 浩, 坂倉 建一, 百村 伸一, 藤田 英雄
    日本心血管インターベンション治療学会抄録集 27回 MO084-MO084 2018年8月  査読有り
  • 津久井 卓伯, 坂倉 建一, 谷口 陽介, 山本 慶, 和田 浩, 百村 伸一, 藤田 英雄
    日本心血管インターベンション治療学会抄録集 27回 MO217-MO217 2018年8月  査読有り
  • 山本 慶, 坂倉 建一, 津久井 卓伯, 谷口 陽介, 和田 浩, 百村 伸一, 藤田 英雄
    日本心血管インターベンション治療学会抄録集 27回 MP165-MP165 2018年8月  査読有り
  • Naoyuki Akashi, Kenichi Sakakura, Yusuke Watanabe, Masamitsu Noguchi, Yousuke Taniguchi, Kei Yamamoto, Hiroshi Wada, Shin-ichi Momomura, Hideo Fujita
    Heart and Vessels 33(7) 713-721 2018年7月1日  査読有り
  • Hirai K, Sakakura K, Watanabe Y, Taniguchi Y, Yamamoto K, Wada H, Momomura SI, Fujita H
    Cardiovascular revascularization medicine : including molecular interventions 19(5 Pt B) 607-612 2018年7月  査読有り
  • Ito M, Wada H, Sakakura K, Ibe T, Ugata Y, Fujita H, Momomura SI
    International heart journal 59(4) 766-771 2018年7月  査読有り
  • Ibe T, Wada H, Sakakura K, Ugata Y, Ito M, Umemoto T, Momomura SI, Fujita H
    International heart journal 59(4) 887-890 2018年7月  査読有り
  • Takunori Tsukui, Kenichi Sakakura, Yousuke Taniguchi, Kei Yamamoto, Hiroshi Wada, Shin-ichi Momomura, Hideo Fujita
    Heart and Vessels 33(5) 498-506 2018年5月1日  査読有り
  • Shingo Yamamoto, Kenichi Sakakura, Yousuke Taniguchi, Kei Yamamoto, Hiroshi Wada, Shin-Ichi Momomura, Hideo Fujita
    International Heart Journal 59(3) 482-488 2018年5月1日  査読有り
  • Kenichi Sakakura, Kei Yamamoto, Yousuke Taniguchi, Yoshimasa Tsurumaki, Shin-ichi Momomura, Hideo Fujita
    Cardiovascular Revascularization Medicine 19(3) 286-291 2018年4月1日  査読有り
  • Yusuke Adachi, Kenichi Sakakura, Tomohisa Okochi, Takaaki Mase, Mitsunari Matsumoto, Hiroshi Wada, Hideo Fujita, Shin-Ichi Momomura
    International heart journal 59(2) 451-454 2018年3月30日  査読有り
    A 32-year-old man with a history of bronchial asthma was referred for low back pain and bilateral femur pain. Vascular sonography revealed bilateral deep vein thrombosis (DVT) from the femoral veins to the popliteal veins. Computed tomography revealed hypoplasia of the inferior vena cava (IVC) and dilated lumbar veins, ascending lumbar veins, and azygos vein as collaterals. There was no evidence of malignant neoplasm. The results of the thrombophilia tests were within normal limits. Hypoplasia of the IVC is a rare cause of DVT. This anomaly should be considered as a cause of bilateral and proximal DVT, in particular, in young patients without major risk factors.
  • Yusuke Watanabe, Kenichi Sakakura, Yousuke Taniguchi, Kei Yamamoto, Hiroshi Wada, Hideo Fujita, Shin-ichi Momomura
    Heart and Vessels 33(3) 226-238 2018年3月1日  査読有り
  • Atsushi Sakaoka, Hisako Terao, Shintaro Nakamura, Hitomi Hagiwara, Toshihito Furukawa, Kiyoshi Matsumura, Kenichi Sakakura
    Circulation: Cardiovascular Interventions 11(2) e005779 2018年2月1日  査読有り
  • Keisuke Yonezu, Kenichi Sakakura, Yusuke Watanabe, Yousuke Taniguchi, Kei Yamamoto, Hiroshi Wada, Shin-ichi Momomura, Hideo Fujita
    Heart and Vessels 33(1) 25-32 2018年1月1日  査読有り

MISC

 33

書籍等出版物

 1

共同研究・競争的資金等の研究課題

 2

学術貢献活動

 4